Chemical Structure (Cobenfy 01)
Cobenfy Capsule, Coated Pellets
Product Images NDC 0003-0125
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cobenfy (NDC 0003-0125). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by E.r. Squibb & Sons, L.l.c., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Cobenfy 02)
Change From Baseline Panss (Cobenfy 03)
This text displays the mean change from baseline in PANSS Total Score for patients treated with both placebo and COBENFY. It shows the number of patients in each group at different time intervals (0, 2, 3, 4, and 5) and their corresponding PANSS Total Score.*
50 mg/20 mg Bottle Labels (Cobenfy 04)
100 mg/20 mg Bottle Labels (Cobenfy 05)
The text is not fully readable.*
125 mg/30 mg Capsule Bottle Label (Cobenfy 06)
This is a medication label for COBENFY capsules containing 125 mg of xanomeline and 30 mg of trospium chloride. The storage instructions advise keeping it between 20°C to 25°C (68°F to 77°F). It is important to keep this medicine out of reach of children. The recommended dosage is one capsule twice daily. This medication is distributed by Bristol-Myers Squibb Company and is a product of Karuna Therapeutics, Inc.*
Starter Pack Carton (Cobenfy 07)
This text provides crucial information regarding the drug COBENFY, a medication marketed by Bristol-Myers Squibb Company. The drug is available in two formulations - 50 mg/20 mg and 100 mg/20 mg capsules - containing xanomeline and trospium chloride as active ingredients. The recommended dosage is one capsule twice daily. The storage conditions require keeping the drug at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The package includes a Starter Pack with 56 capsules for a 28-day dosing regimen. Remember to keep all drugs out of the reach of children.*
Sample Titration Pack (Image 01)
This is a professional sample containing a titration pack of xanomeline and trospium chloride capsules for evaluation purposes. The pack includes 14 capsules to be taken over 7 days, with a specific dosage regimen provided for each day to follow.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
